Repeated Stereotactic Radiotherapy for Local Brain Metastases Failure or Distant Brain Recurrent: A Retrospective Study of 184 Patients

Background: The main advantages of stereotactic radiotherapy (SRT) are to delay whole-brain radiotherapy (WBRT) and to deliver ablative doses. Despite this efficacy, the risk of distant brain metastases (BM) one year after SRT ranges from 26% to 77% and 20 to 40% of patients required salvage treatme...

Full description

Bibliographic Details
Main Authors: Laure Kuntz, Clara Le Fèvre, Delphine Jarnet, Audrey Keller, Philippe Meyer, Christophe Mazzara, Hélène Cebula, Georges Noel, Delphine Antoni
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/15/20/4948